Vaccine Effectiveness Drops from 90% to 50% Versus South Africa Variant

Clinical trial data on two COVID-19 vaccines are less protective versus the South Africa coronavirus variant. Novavax reported midstage trial results on Thursday that showed its vaccine was 50%...

[[ This is a content summary only. Visit my website for full links, other content, and more! ]]